Relación T3/T4 en la enfermedad de la tiroides.

Same author

Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer.

Oncogenesis·2015

Same author

Clinical application of triiodothyronine measurement.

Canadian Medical Association journal·2010

Same author

Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.

Journal of endocrinological investigation·2004

Same author

Requirement of co-factors for the ligand-mediated activity of the insect ecdysteroid receptor in yeast.

Journal of molecular endocrinology·2001

Same author

Cause of death in patients with well-differentiated thyroid carcinoma.

The Laryngoscope·2001

Same author

GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor.

Molecular endocrinology (Baltimore, Md.)·2000

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Relación T3/T4 en la enfermedad de la tiroides.

Videos de Conceptos Relacionados

Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer.

Clinical application of triiodothyronine measurement.

Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.

Requirement of co-factors for the ligand-mediated activity of the insect ecdysteroid receptor in yeast.

Cause of death in patients with well-differentiated thyroid carcinoma.

GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Videos de Experimentos Relacionados

Relación T3/T4 en la enfermedad de la tiroides.

Videos de Conceptos Relacionados

Artículos Relacionados

Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer.

Clinical application of triiodothyronine measurement.

Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.

Requirement of co-factors for the ligand-mediated activity of the insect ecdysteroid receptor in yeast.

Cause of death in patients with well-differentiated thyroid carcinoma.

GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.